Some lncRNAs are protective to DCM, such as H19. These lncRNAs are down-regulated in DCM [57], and their overexpression in the heart is considered as a therapeutic strategy for DCM [58]. The gene discussed is H19; the disease is familial dilated cardiomyopathy.